Calamos Advisors LLC - BIOMARIN PHARMACEUTICAL INC ownership

Back to all holdings Add to watchlist

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8.

Links
Filings
Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2020$2,848,000
-78.3%
2,848,000
-71.4%
0.02%
-80.6%
Q2 2020$13,114,000
-62.0%
9,964,000
-69.4%
0.09%
-65.7%
Q1 2020$34,509,000
-35.2%
32,553,000
-33.6%
0.27%
+3.0%
Q4 2019$53,288,000
+4.0%
49,022,000
-1.0%
0.26%
-5.7%
Q3 2019$51,243,000
-8.1%
49,525,000
-0.0%
0.28%
-10.0%
Q2 2019$55,756,000
-0.2%
49,533,000
+0.8%
0.31%
-11.2%
Q1 2019$55,878,000
+5.3%
49,118,000
+3.2%
0.35%
-0.3%
Q4 2018$53,058,000
-4.8%
47,578,000
+2.5%
0.35%
+14.0%
Q3 2018$55,748,000
+3.1%
46,415,000
+1.8%
0.31%
-7.3%
Q2 2018$54,089,000
+7.1%
45,603,000
+0.0%
0.33%
+0.6%
Q1 2018$50,500,000
+58.5%
45,583,000
+70.0%
0.33%
+103.1%
Q4 2017$31,856,000
+40.8%
26,816,000
+42.6%
0.16%
-7.4%
Q3 2017$22,627,000
+1.6%
18,801,000
+1.0%
0.18%
+6.1%
Q2 2017$22,265,000
-0.7%
18,614,000
-1.5%
0.16%
-6.2%
Q1 2017$22,414,000
-1.3%
18,902,000
-1.9%
0.18%
-2.8%
Q4 2016$22,710,000
-6.2%
19,264,000
-0.7%
0.18%
+4.6%
Q3 2016$24,221,000
-10.6%
19,403,000
-17.0%
0.17%
-8.9%
Q2 2016$27,088,000
-35.4%
23,382,000
-33.7%
0.19%
-31.7%
Q1 2016$41,907,000
-11.7%
35,279,000
-0.2%
0.28%
-7.9%
Q4 2015$47,484,000
-0.3%
35,353,000
+0.4%
0.30%
-7.9%
Q3 2015$47,628,000
-15.9%
35,219,000
-0.6%
0.33%
-6.3%
Q2 2015$56,644,000
+16.5%
35,415,000
+10.3%
0.35%
+14.8%
Q1 2015$48,609,000
+23.6%
32,111,000
-0.4%
0.30%
+17.3%
Q4 2014$39,341,000
+4.6%
32,229,000
-5.4%
0.26%
+3.6%
Q3 2014$37,600,000
-19.3%
34,053,000
-23.0%
0.25%
-14.9%
Q2 2014$46,596,000
+22.4%
44,222,000
+28.9%
0.30%
+21.4%
Q1 2014$38,078,000
+1.7%
34,303,000
-1.2%
0.24%
+2.1%
Q4 2013$37,446,000–34,712,000–0.24%–
 Download
Other shareholders

There were no reported owners of BIOMARIN PHARMACEUTICAL INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders